Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?

Anatol J Cardiol. 2020; 24(1): 19-20 | DOI: 10.14744/AnatolJCardiol.2020.73232

Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?

Imdat Erođlu¹, Burcu Çelik Erođlu¹, Ođuz Abdullah Uyarođlu², Gülay Sain Güven²
¹Department of Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey
²Department of General Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey

Keywords: COVID-19, Angiotensin receptor blockers, Angiotensin Enzyme Inhibitors, Statins, Heparin

Imdat Erođlu, Burcu Çelik Erođlu, Ođuz Abdullah Uyarođlu, Gülay Sain Güven. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?. Anatol J Cardiol. 2020; 24(1): 19-20

Corresponding Author: Ođuz Abdullah Uyarođlu, Türkiye

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Send email to author

Similar articles

PubMed

Google Scholar